• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

硝苯地平(可立平)治疗动脉高血压

[Nifedipine (corinfar) in the treatment of arterial hypertension (AHT)].

作者信息

Tămaş S I, Roman L

出版信息

Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna. 1989 Mar-Apr;41(2):143-7.

PMID:2573128
Abstract

The paper studies the effect of a blocking agent, calcium-niphedipine (corinfar), single or associated with other hypertensors (diuretic, sympathico-colitic), in a dose of 30 mm (3 X 10 mg) administered for about 8-10 days on a lot of 90 patients, men and women, with essentially noncomplicated AHT or associated with: pyelonephritis, cardiac insufficiency, ischemic cerebral stroke, rhythm and conduction disturbances. The systolic AT values of the patients ranged between 160 and 300 mmHg and the diastolic AT between 90 and 150 mmHg. The systolic AT decreased significantly with 40-117 mmHg and the diastolic AT with 15-55 mmHg. The drug was well tolerated and no side effect was noticed. In two cases, the AT values were not influenced by the treatment.

摘要

该论文研究了一种阻滞剂硝苯地平钙(可立平)单独使用或与其他降压药(利尿剂、交感神经阻滞剂)联合使用的效果,以30毫克(3×10毫克)的剂量对90名男女患者给药约8至10天,这些患者患有基本无并发症的高血压或合并有:肾盂肾炎、心脏功能不全、缺血性脑卒、心律和传导紊乱。患者的收缩压范围在160至300毫米汞柱之间,舒张压在90至150毫米汞柱之间。收缩压显著下降了40至117毫米汞柱,舒张压下降了15至55毫米汞柱。该药物耐受性良好,未观察到副作用。有两例患者的血压值不受治疗影响。

相似文献

1
[Nifedipine (corinfar) in the treatment of arterial hypertension (AHT)].硝苯地平(可立平)治疗动脉高血压
Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna. 1989 Mar-Apr;41(2):143-7.
2
[The treatment of hypertensive crisis with nifedipine as the basis].以硝苯地平为基础治疗高血压危象
Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna. 1989 Nov-Dec;41(6):529-38.
3
Study population and treatment titration in the International Nifedipine GITS Study: Intervention as a Goal in Hypertension Treatment (INSIGHT).国际硝苯地平控释片研究:高血压治疗目标干预(INSIGHT)中的研究人群与治疗滴定
J Hypertens. 1998 Dec;16(12 Pt 2):2113-6.
4
Double-blind, placebo-controlled trial of twice-daily nifedipine as a step-2 agent in mild essential hypertension.硝苯地平每日两次作为轻度原发性高血压二级治疗药物的双盲、安慰剂对照试验。
J Clin Hypertens. 1987 Dec;3(4):579-88.
5
[Nifedipine in the treatment of arterial hypertension].硝苯地平治疗动脉高血压
Vutr Boles. 1987;26(1):57-60.
6
[Cicletanine administered with other antihypertensive agents].[与其他抗高血压药物联合使用的西氯他宁]
Arch Mal Coeur Vaiss. 1989 Nov;82 Spec No 4:109-12.
7
[Nifedipine in the treatment of hypertension. An echocardiographic assessment of the hemodynamic effects].
Ter Arkh. 1989;61(8):10-3.
8
Treatment of mild-to-moderate hypertension with calcium channel blockers: a multicentre comparison of once-daily nifedipine GITS with once-daily amlodipine.钙通道阻滞剂治疗轻至中度高血压:一日一次硝苯地平控释片与一日一次氨氯地平的多中心比较
Curr Med Res Opin. 2003;19(3):226-37. doi: 10.1185/030079903125001677.
9
[Changes in central and cerebral hemodynamics in patients with hypertension after a single-dose administration of corinfar].[单次服用科立福后高血压患者的中枢及脑血流动力学变化]
Klin Med (Mosk). 1989 Mar;67(3):37-9.
10
[The comparative efficacy and prognosis of the long-term treatment with korinfar of men and women suffering from hypertension].[科林法尔对男性和女性高血压患者进行长期治疗的比较疗效及预后]
Ter Arkh. 1991;63(8):52-5.